TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV ...
VANCOUVER, BC - December 2, 2025 (NEWMEDIAWIRE) - Neurothera Labs Inc. (TSXV: NTLX) ("Neurothera" or the "Company"), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd.